Literature DB >> 12604610

The mammalian target of rapamycin (mTOR) partner, raptor, binds the mTOR substrates p70 S6 kinase and 4E-BP1 through their TOR signaling (TOS) motif.

Hiroki Nojima1, Chiharu Tokunaga, Satoshi Eguchi, Noriko Oshiro, Sujuti Hidayat, Ken-ichi Yoshino, Kenta Hara, Noriaki Tanaka, Joseph Avruch, Kazuyoshi Yonezawa.   

Abstract

The mammalian target of rapamycin (mTOR) controls multiple cellular functions in response to amino acids and growth factors, in part by regulating the phosphorylation of p70 S6 kinase (p70S6k) and eukaryotic initiation factor 4E-binding protein 1 (4E-BP1). Raptor (regulatory associated protein of mTOR) is a recently identified mTOR binding partner that also binds p70S6k and 4E-BP1 and is essential for TOR signaling in vivo. Herein we demonstrate that raptor binds to p70S6k and 4E-BP1 through their respective TOS (conserved TOR signaling) motifs to be required for amino acid- and mTOR-dependent regulation of these mTOR substrates in vivo. A point mutation of the TOS motif also eliminates all in vitro mTOR-catalyzed 4E-BP1 phosphorylation and abolishes the raptor-dependent component of mTOR-catalyzed p70S6k phosphorylation in vitro. Raptor appears to serve as an mTOR scaffold protein, the binding of which to the TOS motif of mTOR substrates is necessary for effective mTOR-catalyzed phosphorylation in vivo and perhaps for conferring their sensitivity to rapamycin and amino acid sufficiency.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12604610     DOI: 10.1074/jbc.C200665200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  248 in total

1.  Impaired overload-induced hypertrophy is associated with diminished mTOR signaling in insulin-resistant skeletal muscle of the obese Zucker rat.

Authors:  Anjaiah Katta; Sudarsanam Kundla; Sunil K Kakarla; Miaozong Wu; Jacqueline Fannin; Satyanarayana Paturi; Hua Liu; Hari S Addagarla; Eric R Blough
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-10-06       Impact factor: 3.619

2.  Different effects of histone deacetylase inhibitors nicotinamide and trichostatin A (TSA) in C17.2 neural stem cells.

Authors:  Haifeng Wang; Hua Cheng; Kai Wang; Tieqiao Wen
Journal:  J Neural Transm (Vienna)       Date:  2012-03-13       Impact factor: 3.575

3.  S6K1(-/-)/S6K2(-/-) mice exhibit perinatal lethality and rapamycin-sensitive 5'-terminal oligopyrimidine mRNA translation and reveal a mitogen-activated protein kinase-dependent S6 kinase pathway.

Authors:  Mario Pende; Sung Hee Um; Virginie Mieulet; Melanie Sticker; Valerie L Goss; Jurgen Mestan; Matthias Mueller; Stefano Fumagalli; Sara C Kozma; George Thomas
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

4.  Possible dual regulatory circuits involving AtS6K1 in the regulation of plant cell cycle and growth.

Authors:  Yun-jeong Shin; Sunghan Kim; Hui Du; Soonyoung Choi; Desh Pal S Verma; Choong-Ill Cheon
Journal:  Mol Cells       Date:  2012-04-17       Impact factor: 5.034

Review 5.  From signal transduction to autophagy of plant cell organelles: lessons from yeast and mammals and plant-specific features.

Authors:  Sigrun Reumann; Olga Voitsekhovskaja; Cathrine Lillo
Journal:  Protoplasma       Date:  2010-08-24       Impact factor: 3.356

6.  mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1.

Authors:  Theodoros Kantidakis; Ben A Ramsbottom; Joanna L Birch; Sarah N Dowding; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-11       Impact factor: 11.205

7.  Conservation, duplication, and loss of the Tor signaling pathway in the fungal kingdom.

Authors:  Cecelia A Shertz; Robert J Bastidas; Wenjun Li; Joseph Heitman; Maria E Cardenas
Journal:  BMC Genomics       Date:  2010-09-23       Impact factor: 3.969

8.  Everolimus inhibits anti-HLA I antibody-mediated endothelial cell signaling, migration and proliferation more potently than sirolimus.

Authors:  Y-P Jin; N M Valenzuela; M E Ziegler; E Rozengurt; E F Reed
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

9.  Phosphoprotein Phosphatase PP2A Regulation of Insulin Receptor Substrate 1 and Insulin Metabolic Signaling.

Authors:  Chirag Mandavia; James R Sowers
Journal:  Cardiorenal Med       Date:  2012-11-16       Impact factor: 2.041

10.  Regulation of elongation phase of mRNA translation in diabetic nephropathy: amelioration by rapamycin.

Authors:  Kavithalakshmi Sataranatarajan; Meenalakshmi M Mariappan; Myung Ja Lee; Denis Feliers; Goutam Ghosh Choudhury; Jeffrey L Barnes; Balakuntalam S Kasinath
Journal:  Am J Pathol       Date:  2007-11-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.